AYTU – Aytu BioPharma Inc.
Aytu BioPharma, Inc.AYTU
$1.81Name : Aytu BioPharma, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $19,668,740.00
EPSttm : -1.16
Aytu BioPharma, Inc.
$1.81
0.00%$0.00000000000000
AYTU — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.03
Margin Of Safety %
-17
Put/Call OI Ratio
EPS Next Q Diff
-0.09
EPS Last/This Y
0.79
EPS This/Next Y
0.52
Price
1.81
Target Price
9.67
Analyst Recom
1
Performance Q
-20.22
Upside
-3,276.6%
Beta
0.22
Ticker: AYTU
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | AYTU | 1.96 | N/A | N/A | 0 |
| 2026-10-13 | AYTU | 2.0283 | N/A | N/A | 0 |
| 2026-10-14 | AYTU | 1.97 | N/A | N/A | 0 |
| 2026-10-15 | AYTU | 2.02 | N/A | N/A | 0 |
| 2026-10-16 | AYTU | 2 | N/A | N/A | 0 |
| 2026-10-19 | AYTU | 2.05 | N/A | N/A | 0 |
| 2026-10-20 | AYTU | 2 | N/A | N/A | 0 |
| 2026-10-21 | AYTU | 2 | N/A | N/A | 0 |
| 2026-10-22 | AYTU | 1.97 | N/A | N/A | 0 |
| 2026-10-23 | AYTU | 1.94 | N/A | N/A | 0 |
| 2026-10-26 | AYTU | 1.93 | N/A | N/A | 0 |
| 2026-10-27 | AYTU | 1.91 | N/A | N/A | 0 |
| 2026-10-28 | AYTU | 1.945 | N/A | N/A | 0 |
| 2026-10-29 | AYTU | 1.98 | N/A | N/A | 0 |
| 2026-10-30 | AYTU | 1.97 | N/A | N/A | 0 |
| 2026-11-02 | AYTU | 1.92 | N/A | N/A | 0 |
| 2026-11-03 | AYTU | 1.95 | N/A | N/A | 0 |
| 2026-11-04 | AYTU | 1.87 | N/A | N/A | 0 |
| 2026-11-05 | AYTU | 1.82 | N/A | N/A | 0 |
| 2026-11-06 | AYTU | 1.8 | N/A | N/A | 0 |
| 2026-11-09 | AYTU | 1.81 | N/A | N/A | 0 |
| 2026-11-10 | AYTU | 1.79 | N/A | N/A | 0 |
| 2026-11-11 | AYTU | 1.84 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | AYTU | 1.99 | -92.7 | - | -0.36 |
| 2026-10-13 | AYTU | 2.01 | -92.7 | - | -0.36 |
| 2026-10-14 | AYTU | 1.99 | -92.7 | - | -0.36 |
| 2026-10-15 | AYTU | 2.02 | -92.7 | - | -0.36 |
| 2026-10-16 | AYTU | 2.05 | -92.7 | - | -0.36 |
| 2026-10-19 | AYTU | 2.00 | -92.7 | - | -0.36 |
| 2026-10-20 | AYTU | 2.00 | -92.7 | - | -0.36 |
| 2026-10-21 | AYTU | 2.00 | -92.7 | - | -0.36 |
| 2026-10-22 | AYTU | 1.97 | -92.7 | - | -0.36 |
| 2026-10-23 | AYTU | 1.95 | -92.7 | - | -0.36 |
| 2026-10-26 | AYTU | 1.93 | -92.7 | - | -0.36 |
| 2026-10-27 | AYTU | 1.90 | -92.7 | - | -0.36 |
| 2026-10-28 | AYTU | 1.95 | -92.7 | - | -0.36 |
| 2026-10-29 | AYTU | 1.98 | -92.7 | - | -0.36 |
| 2026-10-30 | AYTU | 1.96 | -92.7 | - | -0.36 |
| 2026-11-02 | AYTU | 1.91 | -92.7 | - | -0.36 |
| 2026-11-03 | AYTU | 1.94 | -92.7 | - | -0.36 |
| 2026-11-04 | AYTU | 1.87 | -92.7 | - | -0.36 |
| 2026-11-05 | AYTU | 1.82 | -92.7 | - | -0.36 |
| 2026-11-06 | AYTU | 1.85 | -92.7 | - | -0.36 |
| 2026-11-09 | AYTU | 1.79 | -92.7 | - | -0.36 |
| 2026-11-10 | AYTU | 1.83 | -92.7 | - | -0.36 |
| 2026-11-11 | AYTU | 1.81 | -92.7 | - | -0.36 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | AYTU | 0.00 | -4.61 | 3.47 |
| 2026-10-13 | AYTU | 0.00 | -4.61 | 3.47 |
| 2026-10-14 | AYTU | 0.00 | -4.61 | 3.47 |
| 2026-10-15 | AYTU | 0.00 | -4.61 | 3.47 |
| 2026-10-16 | AYTU | 0.00 | -4.61 | 3.47 |
| 2026-10-19 | AYTU | 0.00 | -4.50 | 3.46 |
| 2026-10-20 | AYTU | 0.00 | -4.50 | 3.46 |
| 2026-10-21 | AYTU | 0.00 | -4.50 | 3.46 |
| 2026-10-22 | AYTU | 0.00 | -4.50 | 3.46 |
| 2026-10-23 | AYTU | 0.00 | -4.50 | 3.46 |
| 2026-10-26 | AYTU | 0.00 | -4.64 | 3.46 |
| 2026-10-27 | AYTU | 0.00 | -4.64 | 3.30 |
| 2026-10-28 | AYTU | 0.00 | -4.64 | 3.30 |
| 2026-10-29 | AYTU | 0.00 | -4.64 | 3.30 |
| 2026-10-30 | AYTU | 0.00 | -4.64 | 3.30 |
| 2026-11-02 | AYTU | 0.00 | -4.61 | 3.30 |
| 2026-11-03 | AYTU | 0.00 | -4.61 | 3.30 |
| 2026-11-05 | AYTU | 0.00 | -4.61 | 3.30 |
| 2026-11-06 | AYTU | 0.00 | -4.61 | 3.30 |
| 2026-11-09 | AYTU | 0.00 | -4.61 | 3.30 |
| 2026-11-10 | AYTU | 0.00 | -4.61 | 3.30 |
| 2026-11-11 | AYTU | 0.00 | -4.61 | 3.03 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.05
Avg. EPS Est. Current Quarter
-0.18
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
Institutional Transactions
-4.61
Beta
0.22
Average Sales Estimate Current Quarter
12
Average Sales Estimate Next Quarter
15
Fair Value
1.5
Quality Score
46
Growth Score
32
Sentiment Score
5
Actual DrawDown %
96.4
Max Drawdown 5-Year %
-98
Target Price
9.67
P/E
Forward P/E
6.8
PEG
P/S
0.35
P/B
0.56
P/Free Cash Flow
6.14
EPS
-1.67
Average EPS Est. Cur. Y
-0.36
EPS Next Y. (Est.)
0.16
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-24.76
Relative Volume
0.33
Return on Equity vs Sector %
-66.8
Return on Equity vs Industry %
-47.1
EPS 1 7Days Diff
-0.3
EPS 1 30Days Diff
-0.29
EBIT Estimation
◆
AYTU
Healthcare
$1.84
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
38.9
Range 1M
18%
Sup Dist
4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
46.3%
EPS NY
143.3%
52W%
5.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+181.7% upside
Upside
+181.7%
Quality
46
MoS
-17%
AYTU — P/E HistoricalBiotechnology
Aytu BioPharma, Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 75
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 15 years of age. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
AYTU
Latest News
—
Caricamento notizie per AYTU…
stock quote shares AYTU – Aytu BioPharma Inc. Stock Price stock today
news today AYTU – Aytu BioPharma Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AYTU – Aytu BioPharma Inc. yahoo finance google finance
stock history AYTU – Aytu BioPharma Inc. invest stock market
stock prices AYTU premarket after hours
ticker AYTU fair value insiders trading